This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Bionomics Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Bionomics.
Key information
-41.6%
Earnings growth rate
n/a
EPS growth rate
| Biotechs earnings growth | 28.3% |
| Revenue growth rate | -52.9% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 15 Sep 2023 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 6/30/2025 | 1 | -71 | -21 | N/A | 1 |
| 6/30/2024 | 1 | -43 | -17 | N/A | 1 |
| 6/30/2023 | 1 | -32 | -20 | N/A | 1 |
| 12/31/2022 | 6 | -25 | -18 | -18 | N/A |
| 9/30/2022 | 6 | -23 | -20 | -20 | N/A |
| 6/30/2022 | 6 | -22 | -22 | -22 | N/A |
| 3/31/2022 | 3 | -22 | -20 | -20 | N/A |
| 12/31/2021 | 0 | -22 | -19 | -19 | N/A |
| 9/30/2021 | 1 | -15 | -13 | -13 | N/A |
| 6/30/2021 | 1 | -9 | -8 | -8 | N/A |
| 3/31/2021 | 1 | -4 | N/A | N/A | N/A |
| 12/31/2020 | 2 | 1 | -5 | -5 | N/A |
| 9/30/2020 | 2 | -3 | -5 | -4 | N/A |
| 6/30/2020 | 3 | -6 | -4 | -4 | N/A |
| 12/31/2019 | 6 | -5 | -9 | -9 | N/A |
| 9/30/2019 | 7 | -8 | -13 | -12 | N/A |
| 6/30/2019 | 7 | -10 | -16 | -16 | N/A |
| 3/31/2019 | 8 | -20 | -15 | -15 | N/A |
| 12/31/2018 | 8 | -28 | -15 | -14 | N/A |
| 9/30/2018 | 10 | -27 | -18 | -17 | N/A |
| 6/30/2018 | 12 | -25 | -21 | -20 | N/A |
| 3/31/2018 | 19 | -15 | -16 | -16 | N/A |
| 12/31/2017 | 27 | -6 | -11 | -11 | N/A |
| 9/30/2017 | 27 | -6 | -6 | -6 | N/A |
| 6/30/2017 | 27 | -7 | -2 | -1 | N/A |
| 3/31/2017 | 22 | -12 | -7 | -7 | N/A |
| 12/31/2016 | 16 | -17 | -13 | -13 | N/A |
| 9/30/2016 | 18 | -17 | N/A | -14 | N/A |
| 6/30/2016 | 19 | -17 | N/A | -15 | N/A |
| 3/31/2016 | 19 | -19 | N/A | -17 | N/A |
| 12/31/2015 | 18 | -21 | N/A | -18 | N/A |
| 9/30/2015 | 17 | -19 | N/A | -6 | N/A |
| 6/30/2015 | 15 | -17 | N/A | 5 | N/A |
| 3/31/2015 | 22 | -6 | N/A | 6 | N/A |
| 12/31/2014 | 29 | 4 | N/A | 7 | N/A |
| 9/30/2014 | 28 | 4 | N/A | -3 | N/A |
| 6/30/2014 | 27 | 3 | N/A | -13 | N/A |
| 3/31/2014 | 19 | -5 | N/A | -9 | N/A |
| 12/31/2013 | 12 | -13 | N/A | -5 | N/A |
| 9/30/2013 | 12 | -11 | N/A | -8 | N/A |
| 6/30/2013 | 12 | -10 | N/A | -10 | N/A |
| 3/31/2013 | 13 | -7 | N/A | -9 | N/A |
| 12/31/2012 | 13 | -4 | N/A | -9 | N/A |
| 9/30/2012 | 12 | -3 | N/A | -6 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: BNOE.F is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: BNOE.F is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: BNOE.F is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: BNOE.F's revenue is expected to decline over the next 3 years (-52.9% per year).
High Growth Revenue: BNOE.F's revenue is forecast to decline over the next 3 years (-52.9% per year).
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if BNOE.F's Return on Equity is forecast to be high in 3 years time